The Washington PostDemocracy Dies in Darkness

Opinion The international community must guarantee equal global access to a covid-19 vaccine

A researcher injects a vaccination against covid-19 from German biotechnology company CureVac to a volunteer at the start of a clinical test series at a clinic in Tuebingen, Germany, on June 22. (Kai Pfaffenbach/Reuters)

“None of us is safe until all of us are safe.”

This statement by United Nations Secretary General António Guterres sums up the momentous challenge ahead. As the world is still in the midst of the deadliest pandemic of the 21st century, with the number of cases still rising at the global level, immunization is our best chance of ending the pandemic at home and across the world — but only if all countries get access to the vaccine.

Covid-19 is wreaking havoc across the world, and no country will be spared its consequences, whether directly through loss of life and health, or indirectly through its impact on the economy, health services, education and many other parts of society. The pandemic is disproportionately affecting populations living in poverty and vulnerable situations.

Thankfully, great efforts, investment and coordination — largely facilitated by the World Health Organization (WHO) — are being directed at putting an end to the pandemic.

Vaccines are the most powerful public health tool and are critical for saving lives. Thanks to vaccines, we have seen good progress in reducing child mortality in recent decades.

At this point in time, with almost 200 potential covid-19 vaccine candidates currently at different stages of development, there is hope that soon one or more will prove to be both safe and effective. What happens next is equally important. This cannot be a race with one winner. When one or more vaccines are successful, it must be a win for all of us.

We cannot allow access to vaccines to increase inequalities within or between countries — whether low-, middle- or high-income. A future covid-19 vaccine can be instrumental in our commitment to achieve one of the key elements in the United Nations’ sustainable development goals: ensuring healthy lives and promoting well-being for all at all ages.

However, manufacturing enough vaccines and doses to cover the whole global population will take time. While global cooperation in terms of resources, expertise and experiences is paramount for developing a vaccine, manufacturing and distributing it while leaving no one behind will truly put global cooperation to the test. But if we are successful, we can beat the virus and pave the way for recovery from the pandemic.

Therefore, we must urgently ensure that vaccines will be distributed according to a set of transparent, equitable and scientifically sound principles. Where you live should not determine whether you live, and global solidarity is central to saving lives and protecting the economy. A managed flow of the vaccine —including for humanitarian settings and other vulnerable countries such as the least developed countries and small island developing states — is the wise and strategic course of action and will benefit countries across the world.

Implementing an organized global flow of vaccines requires a strong multilateral mechanism ensuring mutual trust, transparency and accountability. A fair and effective vaccine allocation mechanism, guided by WHO advice and based on needs rather than means, should focus on saving lives and protecting health systems.

There are already local, regional and global initiatives to secure vaccine availability, including the important Covid-19 Vaccine Global Access (COVAX) Facility; we believe these initiatives should be coordinated and mutually reinforcing. We particularly recognize the WHO’s role as the leading global health agency, but also ongoing efforts by Gavi (the Vaccine Alliance) and the Coalition for Epidemic Preparedness Innovations (CEPI) as part of the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. We also acknowledge the role of the International Vaccine Institute (IVI) in making vaccines available and accessible for vulnerable populations in developing countries and fully support the U.N. secretary general’s important leadership in ensuring a coordinated process.

A successfully managed vaccine distribution will also be a cornerstone of strengthening multilateralism for the future — as was the Security Council resolution on covid-19 drafted by France and Tunisia, demanding a global cease-fire in armed conflicts — and an important step toward coming back stronger together.

We call on global leaders to commit to contributing to an equitable distribution of the covid-19 vaccine, based on the spirit of a greater freedom for all.

Justin Trudeau, prime minister of Canada

Sahle-Work Zewde, president of Ethiopia

Moon Jae-in, president of the Republic of Korea

Jacinda Ardern, prime minister of New Zealand

Cyril Ramaphosa, president of South Africa (also chairperson of the African Union)

Pedro Sánchez Pérez-Castejón, prime minister of Spain

Stefan Lofven, prime minister of Sweden

Elyes Fakhfakh, prime minister of the Republic of Tunisia

Read more:

Joseph G. Allen: Need some good news about covid-19? Here are six reasons for optimism.

Steven Joffe and Holly Fernandez Lynch: The FDA should not rush a covid-19 vaccine

The Post’s View: Speed is essential in developing this vaccine. But so is safety.

Henry Olsen: Three cheers for Big Pharma as it rushes to develop a vaccine

The Post’s View: The science is challenging. But we should be hopeful for a covid-19 vaccine or drug.

Letter to the Editor: We shouldn’t care who wins the vaccine ‘race’

Coronavirus: What you need to know

The latest: The CDC has loosened many of its recommendations for battling the coronavirus, a strategic shift that puts more of the onus on individuals to limit viral spread. A new study on long covid suggests many people don’t fully recover even months after infection.

Variants: BA.5 is the most recent omicron subvariant, and it’s quickly become the dominant strain in the U.S. Here’s what to know about it, and why vaccines may only offer limited protection.

Vaccines: The CDC recommends that everyone age 12 and older get an updated coronavirus booster shot designed to target both the original virus and the omicron variant. You’re eligible if it has been at least two months since your initial vaccine or your last booster. The FDA has cleared updated coronavirus booster shots for children as young as 5. An initial vaccine series for children under 5 became available this summer. Here’s how vaccine efficacy could be affected by your prior infections and booster history.

Guidance: CDC guidelines have been confusing — if you get covid, here’s how to tell when you’re no longer contagious. We’ve also created a guide to help you decide when to keep wearing face coverings.

Where do things stand? See the latest coronavirus numbers in the U.S. and across the world. The omicron variant is behind much of the recent spread.

For the latest news, sign up for our free newsletter.

Loading...